Skip to main content
Caplight Logo









dawn-bio GmbH

dawn-bio GmbH

Private
ViennaHealthcare & Life Scienceshttps://dawn-bio.com

Last Round

Grant

Feb 9, 2026

Total Funding Raised

$1.95M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

dawn-bio GmbH operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Grant round in February 2026.

dawn-bio GmbH is a biotechnology company that develops stem-cell-based models of human embryogenesis to improve IVF outcomes and reproductive health research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

dawn-bio GmbH Comparables

Compare dawn-bio GmbH with similar companies based on industry and business-model similarity.

dawn-bio GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IVFmicro
83%
Overture Life
78%
Nexpring Health
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

dawn-bio GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 9, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Peter Greiner

CEO & Co-Founder

Founding Team

For institutional investors. Book with your work email.

dawn-bio GmbH Investors

Notable investors and investment history

dawn-bio GmbH investors
InvestorRounds
Wieland CapitalSeed
European Innovation CouncilGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 80% MoM, reaching 1.7K.

  • Apr 25, 2026

    Monthly visitors grew 243% MoM, reaching 1.4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

dawn-bio GmbH Filings

Explore SEC and related filing metadata, where available.

dawn-bio GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about dawn-bio GmbH's valuation, stock price, and market status.

Is dawn-bio GmbH a public or private company?

dawn-bio GmbH is a private company.

What is the current stock price of dawn-bio GmbH?

dawn-bio GmbH is a private company, so its shares have no public market price. Caplight tracks dawn-bio GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is dawn-bio GmbH worth (valuation)?

Valuation information for dawn-bio GmbH is not publicly available.

Can I buy dawn-bio GmbH stock?

dawn-bio GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was dawn-bio GmbH's last funding round?

dawn-bio GmbH's most recent funding round was Grant on February 9, 2026.

Who are the main investors in dawn-bio GmbH?

Key investors in dawn-bio GmbH include Wieland Capital, European Innovation Council.

Will dawn-bio GmbH IPO soon?

No public IPO plans have been announced for dawn-bio GmbH.

How can I track dawn-bio GmbH secondary market activity?

Caplight tracks bids, offers, and trades in dawn-bio GmbH's shares on secondary markets.

Firmographic Details

HeadquartersVienna
Employee Range10
Year Founded2023
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?